Cargando…

Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery

OBJECTIVES: cardiopulmonary bypass (CPB) can be complicated by vasoplegia that is refractory to vasopressors. Methylene blue (MB) represents an alternative in such cases. PATIENTS AND METHODS: Retrospective observational historical control-matched study. From 2010 to 2015, all patients who received...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habib, Aly Makram, Elsherbeny, Ahmed Galal, Almehizia, Rayd Abdelaziz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879859/ https://www.ncbi.nlm.nih.gov/pubmed/29657374 http://dx.doi.org/10.4103/ijccm.IJCCM_494_17

Ejemplares similares

Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017)

Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised
por: Evora, Paulo Roberto Barbosa, et al.
Publicado: (2015)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
por: Mazzeffi, Michael, et al.
Publicado: (2017)

The Use of Intravenous Hydroxocobalamin as a Rescue in Methylene Blue-resistant Vasoplegic Syndrome in Cardiac Surgery
por: Cai, Yi, et al.
Publicado: (2017)

Use of methylene blue in vasoplegic syndrome that developed during non-cardiac surgery - A case report -
por: Oh, In Duk, et al.
Publicado: (2019)

Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding
por: Habib, Aly Makram
Publicado: (2016)

The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery
por: Petermichl, Walter, et al.
Publicado: (2021)

Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass
por: Peyko, Vincent, et al.
Publicado: (2021)

Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue
por: Manji, Farheen, et al.
Publicado: (2017)

Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report
por: Workum, Jessica D., et al.
Publicado: (2023)

Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study
por: Kofler, Othmar, et al.
Publicado: (2022)

After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis
por: Lim, Pascal, et al.
Publicado: (2022)

Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? “Reasons That Reason Itself Does Not Know...”
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

Vasoplegic Syndrome and Anaesthesia: A Narrative Review
por: Gökdemir, Begüm Nemika, et al.
Publicado: (2023)

Complexities of Characterizing “Vasoplegics”
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

Iatrogenic Withdrawal Syndrome in the Pediatric Cardiac Intensive Care Unit: Incidence, Risk Factors and Outcome
por: Habib, Eiad, et al.
Publicado: (2021)

Delayed diagnosis of postcardiac injury syndrome
por: Nishimura, Mitsushige, et al.
Publicado: (2019)

Vasoplegic syndrome in patients undergoing heart transplantation
por: Qin, Tong-xin, et al.
Publicado: (2023)

Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options
por: Busse, Laurence W., et al.
Publicado: (2020)

Definitions and pathophysiology of vasoplegic shock
por: Lambden, Simon, et al.
Publicado: (2018)

Reply to: Complexities of Characterizing Vasoplegics
por: Magoon, Rohan, et al.
Publicado: (2023)

Comment on “Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options”
por: Ortoleva, Jamel, et al.
Publicado: (2020)

Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care
por: Ltaief, Zied, et al.
Publicado: (2022)

Hematuria in a child eight hours, postcardiac surgery
por: Singh, Sarvesh Pal
Publicado: (2015)

Effect of Goal-directed Hemodynamic Therapy in Postcardiac Surgery Patients
por: Patel, Hasmukh, et al.
Publicado: (2020)

Methylene Blue Spray for Identification of Parathyroid Glands During Thyroidectomy
por: Monib, Sherif, et al.
Publicado: (2020)

Postcardiac Injury Syndrome after Percutaneous Coronary Intervention
por: Park, Jin-Seok, et al.
Publicado: (2010)

Preoperative Fibrinogen Level and Postcardiac Surgery Morbidity and Mortality Rates
por: Fricault, Pierre, et al.
Publicado: (2022)

Methylene Blue: Revisited
por: Ginimuge, Prashant R., et al.
Publicado: (2010)

Methylene-Blue in Fevers
por: Frost, G. H.
Publicado: (1908)

Clinical Usage of High-flow Oxygenation in Postcardiac Surgery Patients
por: Jabbari, Ali, et al.
Publicado: (2019)

Successful repair of a postcardiac surgery ascending aortic pseudoaneurysm
por: Contrafouris, Constantinos, et al.
Publicado: (2022)

Methylene blue fluorescence of the ureter during colorectal surgery
por: Barnes, Thomas G., et al.
Publicado: (2018)

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
por: Ayers, Brian, et al.
Publicado: (2020)

A Case of Postcardiac Injury Syndrome Presenting as Acute Mediastinitis
por: Lim, Hong-Kyu, et al.
Publicado: (2009)

Paint It Blue: Methylene Blue in Burn Care
por: Goodenough, Christopher J., et al.
Publicado: (2020)

Methylene blue in covid-19
por: Scigliano, Giulio, et al.
Publicado: (2021)

Vasoactive-ventilation-renal score in predicting outcome postcardiac surgery in children
por: Alam, Shahzad, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aavmmgsbruj5g58j572efou5jc